Ensysce Biosciences (ENSCW) Change in Account Payables (2020 - 2025)
Historic Change in Account Payables for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to -$579374.0.
- Ensysce Biosciences' Change in Account Payables fell 13334.07% to -$579374.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year decrease of 29239.06%. This contributed to the annual value of -$578928.0 for FY2024, which is 5309.62% up from last year.
- Ensysce Biosciences' Change in Account Payables amounted to -$579374.0 in Q3 2025, which was down 13334.07% from $427537.0 recorded in Q2 2025.
- In the past 5 years, Ensysce Biosciences' Change in Account Payables registered a high of $2.1 million during Q2 2022, and its lowest value of -$1.8 million during Q3 2022.
- In the last 5 years, Ensysce Biosciences' Change in Account Payables had a median value of -$323538.0 in 2023 and averaged -$78297.1.
- Per our database at Business Quant, Ensysce Biosciences' Change in Account Payables tumbled by 86591.91% in 2021 and then surged by 107114.91% in 2022.
- Ensysce Biosciences' Change in Account Payables (Quarter) stood at -$170754.0 in 2021, then skyrocketed by 1071.15% to $1.7 million in 2022, then plummeted by 52.17% to $793088.0 in 2023, then plummeted by 165.73% to -$521262.0 in 2024, then fell by 11.15% to -$579374.0 in 2025.
- Its Change in Account Payables was -$579374.0 in Q3 2025, compared to $427537.0 in Q2 2025 and -$741784.0 in Q1 2025.